Sanlam Limited (SLM.JO)
ZAc 8709.0
(0.02%)
ZAc 8709.0
(0.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -29.27 Billion | 6.81 Billion | -1.45 Billion | -6.08 Billion | 6.64 Billion | 10.76 Billion |
| Net Income | 11.59 Billion | 17.01 Billion | 17.5 Billion | 7.43 Billion | 14.56 Billion | 16.96 Billion |
| Depreciation & Amortization | 1.19 Billion | 1.58 Billion | 2.28 Billion | 2.46 Billion | 2.42 Billion | 1.01 Billion |
| Deferred income taxes | -2.85 Billion | - | -100.77 Billion | -49.14 Billion | -79.15 Billion | -5.47 Billion |
| Stock-based compensation | 468 Million | 531 Million | 506 Million | 506 Million | 2.11 Billion | 385 Million |
| Change in working capital | -42.71 Billion | 14.27 Billion | 78.02 Billion | 33.14 Billion | 64.95 Billion | -3.26 Billion |
| Other non-cash items | 3.04 Billion | -26.59 Billion | 1.01 Billion | -484 Million | 1.74 Billion | 1.13 Billion |
| Investing Cash Flow | 18.01 Billion | -1.15 Billion | 695 Million | -1.73 Billion | -509 Million | -6.76 Billion |
| Investments in PPE | -1.09 Billion | -1.23 Billion | -586 Million | -737 Million | - | - |
| Acquisitions | -1.33 Billion | -154 Million | 1.39 Billion | -1.09 Billion | -509 Million | -6.76 Billion |
| Investment purchases | -850 Million | -26.22 Billion | -13.62 Billion | -18.68 Billion | -18.81 Billion | -7.32 Billion |
| Sales/Maturities of investments | 21.19 Billion | 277 Million | 18 Million | 1.25 Billion | - | 90 Million |
| Other Investing Activities | 102 Million | 26.17 Billion | 13.49 Billion | 17.52 Billion | 18.81 Billion | 490 Million |
| Financing Cash Flow | -10.42 Billion | -1.12 Billion | 172 Million | 1.79 Billion | 2.5 Billion | 4.05 Billion |
| Debt repayment | -336 Million | -1.27 Billion | -1.84 Billion | -664 Million | -299 Million | -3.07 Billion |
| Dividends payments | -9.6 Billion | -8.44 Billion | -6.96 Billion | -8.45 Billion | -7.43 Billion | -6.84 Billion |
| Common Stock Repurchased | -1.28 Billion | -1.7 Billion | -632 Million | -1.24 Billion | -8.4 Billion | -1.05 Billion |
| Common Stock Issuance | 470 Million | 755 Million | 261 Million | 8.45 Billion | 7.79 Billion | 5.63 Billion |
| Other Financing Activities | 329 Million | 9.54 Billion | 5.1 Billion | 3.69 Billion | 10.84 Billion | 5 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -42.71 Billion | 14.27 Billion | 78.02 Billion | 33.14 Billion | 64.95 Billion | -1.08 Billion |
| Cash at beginning of period | 36.86 Billion | 50.07 Billion | 48.41 Billion | 52.73 Billion | 63.34 Billion | 55.41 Billion |
| Cash at end of period | 25.82 Billion | 54.77 Billion | 50.07 Billion | 48.41 Billion | 71.65 Billion | 63.34 Billion |
| Capital Expenditure | -1.09 Billion | -1.23 Billion | -586 Million | -737 Million | - | - |
| Effect of forex changes on cash | 700 Million | 162 Million | 2.25 Billion | 1.69 Billion | -325 Million | -124 Million |
| Net cash flow / Change in cash | -11.03 Billion | 4.69 Billion | 1.66 Billion | -4.32 Billion | 8.31 Billion | 7.92 Billion |
| Free Cash Flow | -30.37 Billion | 5.58 Billion | -2.03 Billion | -6.81 Billion | 6.64 Billion | 10.76 Billion |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.63 Billion | 11.59 Billion | 6.66 Billion | 3.28 Billion | 4.93 Billion | 3.95 Billion |
| Depreciation & Amortization | 715 Million | 1.19 Billion | 609 Million | 276.5 Million | 585 Million | 320.5 Million |
| Deferred income taxes | - | -2.85 Billion | -1.31 Billion | - | -1.31 Billion | - |
| Stock-based compensation | - | 468 Million | 92.5 Million | 92.5 Million | 141.5 Million | 141.5 Million |
| Change in working capital | 42.45 Billion | -42.71 Billion | -33.18 Billion | -16.57 Billion | -9.53 Billion | -4.76 Billion |
| Other non-cash items | -29.9 Billion | 3.04 Billion | -6.22 Billion | 5.74 Billion | 9.26 Billion | 3.47 Billion |
| Investing Cash Flow | -10.57 Billion | 18.01 Billion | 17.23 Billion | -716.5 Million | 785 Million | -501 Million |
| Investments in PPE | -411 Million | -1.09 Billion | -454 Million | -245.5 Million | -645 Million | -130.5 Million |
| Acquisitions | 1.79 Billion | -1.33 Billion | -910 Million | -761.5 Million | -420 Million | -457 Million |
| Investment purchases | -11.97 Billion | -850 Million | -433 Million | - | -417 Million | - |
| Sales/Maturities of investments | - | 21.19 Billion | 18.95 Billion | - | 2.24 Billion | - |
| Other Investing Activities | 22 Million | 102 Million | 80 Million | 290.5 Million | 22 Million | 86.5 Million |
| Financing Cash Flow | -9.3 Billion | -10.42 Billion | -1.33 Billion | -826.5 Million | -9.08 Billion | -4.74 Billion |
| Debt repayment | -1.23 Billion | -336 Million | -488 Million | - | -824 Million | - |
| Dividends payments | -8.88 Billion | -9.6 Billion | -1.15 Billion | -575.5 Million | -8.45 Billion | -4.22 Billion |
| Common Stock Repurchased | -505 Million | -1.28 Billion | 20 Million | - | -1.3 Billion | -650.5 Million |
| Common Stock Issuance | 1.51 Billion | 470 Million | 470 Million | - | 359 Million | - |
| Other Financing Activities | -207 Million | 329 Million | -271 Million | -251 Million | 132.5 Million | 132.5 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 42.45 Billion | -42.71 Billion | -16.57 Billion | -16.57 Billion | -4.76 Billion | -4.76 Billion |
| Cash at beginning of period | 25.82 Billion | 36.86 Billion | 34.5 Billion | - | 23.55 Billion | - |
| Cash at end of period | 27.9 Billion | 25.82 Billion | 25.82 Billion | -9.12 Billion | 34.5 Billion | -1.35 Billion |
| Capital Expenditure | -411 Million | -1.09 Billion | -454 Million | -245.5 Million | -645 Million | -130.5 Million |
| Effect of forex changes on cash | - | 700 Million | -404 Million | -404 Million | 754 Million | 754 Million |
| Net cash flow / Change in cash | 2.07 Billion | -11.03 Billion | -8.67 Billion | -9.12 Billion | 10.94 Billion | -1.35 Billion |
| Free Cash Flow | 21.06 Billion | -30.37 Billion | -33.8 Billion | -7.42 Billion | 3.43 Billion | 3 Billion |
YOGI
SGL
3577
3311
BORORENEW
BIOTEC